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ABREVIATIONS 
HIT – High intensity interval training 
MICT – Moderate intensity continuous training 
CON – Control day of no exercise 
CGMS – Continuous glucose monitor system 
CHO - Carbohydrate 
EXTOD – Exercising for type 1 diabetes 
Wmax – Maximal power output 
V& O2peak – Peak oxygen consumption
Aims – To compare the effect of a bout of high-intensity interval training (HIT) with a bout 
of moderate-intensity continuous training (MICT) on glucose concentrations over the 
subsequent 24h period. 
METHODS – Fourteen people with type 1 diabetes (duration of type 1 diabetes 8.2±1.4 
years), all on basal-bolus regimen, completed a randomised, counterbalanced, crossover 
study. Continuous glucose monitoring was used to assess glycaemic control following a 
single bout of HIT (6 x 1min intervals) and 30 mins of moderate-intensity continuous training 
(MICT) on separate days, compared to a non-exercise control day (CON). Exercise was 
undertaken following an overnight fast with omission of short-acting insulin. Capillary blood 
glucose samples were recorded pre and post-exercise to assess the acute changes in 
glycaemia during HIT and MICT. 
RESULTS – There was no difference in the incidence of or percentage time spent in 
hypoglycaemia, hyperglycaemia or target glucose range over the 24h and nocturnal period 
(24:00-06:00h) between CON, HIT and MICT (P>0.05). Blood glucose concentrations were 
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not significantly (P=0.49) different from pre to post-exercise with HIT (+0.39±0.42 mmol/L) 
or MICT (-0.39±0.66 mmol/L), with no difference between exercise modes (P=1.00). 
CONCLUSIONS – HIT or 30 mins of MICT can be carried out after an overnight fast with 
no increased risk of hypoglycaemia or hyperglycaemia, and provided the pre-exercise glucose 
concentration is 7-14 mmol/L, no additional carbohydrate ingestion is necessary to undertake 
these exercises. As HIT is a time-efficient form of exercise, the efficacy and safety of long-
term HIT should now be explored.  
FASTED HIGH-INTENSITY INTERVAL TRAINING AND MODERATE-INTENSITY CONTINUOUS 
EXERCISE ARE NOT ASSOCIATED WITH A DETRIMENTAL 24-HOUR BLOOD GLUCOSE 
PROFILE IN PEOPLE WITH TYPE 1 DIABETES. 
INTRODUCTION 
Clinical guidelines recommend that people with type 1 diabetes perform at least 150 minutes 
of moderate-intensity physical activity per week 1. However, a single bout of moderate-
intensity exercise in people with type 1 diabetes is associated with marked decreases in blood 
glucose concentrations and thus an increased risk of hypoglycaemia 2,3. The potentially large 
drop in blood glucose during exercise and associated fear of acute and nocturnal 
hypoglycaemia means that many patients avoid exercise 4, with long-tern cardio-metabolic 
health consequences. Clearly, safe and effective alternative forms of exercise that minimise 
the perceived barriers to exercise are needed for people with type 1 diabetes. 
Lack of time has also been cited as an important barrier to exercise in people with type 1 
diabetes 4. High intensity interval training (HIT), consisting of repeated bouts of high 
intensity exercise interspersed with low-intensity recovery, is purported as a time-efficient 
alternative to traditional moderate-intensity continuous training (MICT) in various groups 
without type 1 diabetes 5. Indeed, because the typical weekly training volume during a HIT 
programme is approximately one third of the time commitment required for MICT 6, HIT is 
able to minimise a perceived “lack of time” as a barrier to exercise. Importantly for people 
with type 1 diabetes, the addition of short bursts of high intensity exercise at regular intervals 
during a bout of MICT has been shown to assist in stabilising blood glucose concentration 
during exercise, and can prevent hypoglycaemia during and up to 2 hours post exercise 7,8. It 
has been proposed that the increase in plasma catecholamines, growth hormone and cortisol 
during vigorous exercise (>80% V& O2max) may offset the glucose lowering effect of MICT 8,9. 
Therefore, in people with type 1 diabetes HIT may maintain blood glucose concentrations 
and reduce the risk of hypoglycaemia both during exercise and overnight. To date, however, 
this has not been investigated.  
The current investigation aimed to determine whether HIT maintained normoglyccaemia 
both during exercise and in the 24 hours following exercise. To achieve this aim, we 
examined the effects of a single bout of HIT and MICT following an overnight fast on acute 
and 24h glucose concentrations in people with type 1 diabetes, compared to a control day 
without exercise. Continuous glucose monitor data were analysed to assess 24h glycaemic 
control following exercise under controlled diet conditions using the most recent guidelines 
10
. Capillary blood sampling was used to assess change in blood glucose concentrations
during the exercise bouts. We hypothesised that blood glucose concentrations would be
maintained following HIT and that the incidence and time spent in hypoglycaemia would be
lower, compared to MICT.
RESEARCH DESIGN AND METHODS  
Fourteen sedentary people with type 1 diabetes (6 men/8 women; age 26 ± 3 years; BMI 27.6 
± 1.3 kg·m-2; V& O2peak 30.8 ± 2.0 ml·kg-1·min-1; duration of type 1 diabetes 8.2 ± 1.4 years) 
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on a basal-bolus insulin regimen completed the study. Exclusion criteria were duration of 
type 1 diabetes <6 months, insulin pump therapy, poor diabetes control (HbA1c > 86 
mmol/mol), poor diabetes control (HbA1c >86 mmol/mol), frequent hypoglycaemia (>5 per 
week) and/or hypoglycaemia unawareness (determined from medical history as patients 
having no symptoms prior to or at the time of a blood sugar ≤70 mg/dl (3.9 mmol/l) within 
the last 3 months), obesity (BMI >30 kg·m-2), pregnancy or planning pregnancy, uncontrolled 
hypertension (>180/100 mmHg), angina, autonomic neuropathy, taking any medication that 
affects heart rate, major surgery planned within 6 weeks of the study, severe nonproliferative 
and unstable proliferative retinopathy. Testing took place in the laboratory of the School of 
Sport and Exercise Sciences at Liverpool John Moores University. The study was approved 
by the Black Country NHS Research Ethics Committee (West Midlands, UK) and all 
participants gave written informed consent to a protocol conforming to the Declaration of 
Helsinki.  
Pre-experimental procedures 
Participants first performed an incremental exercise test to exhaustion on an 
electromagnetically braked cycle ergometer (Excalibur Sport V2.0, Lode, Groningen, The 
Netherlands) to determine maximal aerobic power output (Wmax) and V& O2peak using an online 
gas collection system (MOXUS modular oxygen uptake system, AEI technologies, 
Pittsburgh, PA). This information was used to determine appropriate workloads for 
subsequent exercise trials. The test consisted of 3-minute stages starting at 60 W, and the 
workload was increased by 35 W at each stage until subjects could not maintain a cadence of 
>50 rpm. V& O2peak was taken as the highest value achieved over a 15 second recording period.
Participants also completed a food diary over a minimum of three days in order to calculate
their habitual caloric and macronutrient intake.
Study design and experimental protocol 
Participants completed a randomised, counterbalanced, crossover experiment, consisting of 3 
intervention periods: control day with no exercise (CON), HIT and MICT (see Fig. 1 for 
protocol overview). Each intervention period lasted 24h during which the effect of a single 
session of exercise on subsequent 24h glycaemic control and risk of hypoglycaemia were 
assessed under standardised dietary, but otherwise free living conditions. Periods were 
identical except for the exercise performed. Prior to the intervention periods participants had 
a Dexcom G4 Platinum CGMS probe (Dexcom, San Diego, CA, USA) inserted 
subcutaneously into the abdomen at least 24 hours prior to the intervention period to allow 
time for a “bedding in” period. Participants were trained on how to use the CGMS and 
instructed to calibrate the device a minimum of four times daily using capillary blood tests. 
Participants were not blinded to the CGMS meaning they could see their glucose values. 
Twenty-four hours after the CGMS was inserted participants completed the control 
intervention. Participants did not attend the laboratory on the control day, but were provided 
with a standardised diet to consume while going about their normal daily activities.  
The standardised diet was matched to each participant’s habitual energy intake and 
consisted of three meals (breakfast, lunch and dinner; 50% CHO; 30% fat; 20% protein). 
Participants were instructed to consume these meals at pre-determined time-points throughout 
the day. Participants only consumed the food provided by the research team during this 
period. Additional snacks were only permitted to prevent hypoglycaemia. The diet was a 2-
day rolling diet, matched for macronutrient and energy content between days, which ensured 
that participants consumed exactly the same food on the experimental days. Participants were 
also instructed to abstain from caffeine, alcohol and vigorous exercise. Participants 
completed a food diary to confirm that they had eaten the prescribed food at the correct times. 
AD
VA
N
CE
 A
RT
IC
LE
:
TH
E 
JO
UR
NA
L 
O
F 
CL
IN
IC
AL
 
EN
D
O
CR
IN
O
LO
G
Y 
& 
M
ET
AB
O
LI
SM
JC
EM
 DOI: 10.1210/jc.2018-01308 
4
Following the control day participants completed the 2 exercise intervention periods in a 
randomised order separated by at least 48h. The exercise intervention periods were identical 
to the control intervention except participants attended the laboratory following an overnight 
fast and having omitted their short-acting insulin to perform a bout of either HIT or MICT. 
Following the exercise, participants left the laboratory and returned to their normal daily 
activities. As on the control day participants were provided with a standardised diet to 
consume. This diet was identical to the control day and participants consumed each meal at 
the same pre-determined time-points throughout the day. Insulin dosage was not recorded. 
Exercise Protocols 
Both exercise protocols were conducted on a stationary cycle ergometer (Excalibur Sport 
V2.0, Lode, Groningen, The Netherlands), and were preceded by a standardised 5 min warm-
up at 50W. MICT consisted of 30 minutes continuous cycling at a workload equivalent to 
65% V& O2peak. HIT consisted of 6 x 1 minute intervals at a workload equivalent to 100% 
V& O2peak, interspersed with 1 minute of rest. As such, the total time commitment of the HIT 
protocol (17 min) was ~half of that of the MICT protocol (35 min).  
Acute change in blood glucose with exercise 
Blood glucose concentration was recorded before and after exercise through capillary 
fingertip sampling. This was to ensure that blood glucose levels were between 7-14 mmol/L, 
in accordance with the guidelines we developed in the Exercising for Type 1 Diabetes 
(EXTOD) study 11, meaning participants were safe to commence exercise and also safe to 
leave following exercise. If blood glucose was <7 mmol/L before exercise, 20g of glucose 
was ingested. If >14 mmol/L, a light walk or insulin was advised, as well as checking blood 
ketones 12.  
Statistical analyses 
Continuous glucose monitor data were downloaded from the device using Dexcom Studioᵀᴹ 
software (12.0.4.6). Data from the CGMS were analysed in accordance to the International 
Consensus on Use of Continuous Glucose monitoring guidelines 10. A one-way ANOVA with 
repeated measures was used to assess glycaemic control between the three conditions using 
the following metrics: percentage of time in level 1 hypoglycaemia (≤3.9 mmol/L), level 2 
hypoglycaemia (≤2.9 mmol/L), time in target range (4-10 mmol/L) and hyperglycaemia (≥10 
mmol/L). Mean glucose and glycaemic variability using coefficient of variation were 
compared between conditions. Episodes of level 1 and 2 hypoglycaemia and hyperglycaemia 
were compared between conditions. The 24h period was defined as 08:00-08:00h and the 
nocturnal period was defined as 24:00-06:00h. A two factor repeated measures ANOVA was 
used to assess whether there was an acute change in blood glucose concentration following 
HIT and MICT in the fasted state with the within-subject factors ‘training mode’ and ‘time 
point’. All analyses were performed using IBM SPSS Statistics for Windows, Version 22.0. 
Armonk, NY: IBM Corp. Data are presented as mean ± SEM and significance was set at 
P≤0.05. 
RESULTS 
24h glycaemic control 
Glucose data from the CGMS are presented in Table 1 and mean continuous glucose monitor 
traces over the 24h period in each condition are shown in Figure 2. The CGMS data revealed 
no differences in the time spent in level 1 hypoglycaemia (≤3.9 mmol/L) over the 24h period 
(P=0.446) or nocturnal period (P=0.944) between the CON, HIT and MICT conditions. 
Similarly, there were no differences in the time spent in level 2 hypoglycaemia (≤2.9 
mmol/L) between the three conditions over the 24h period (P=0.518) or nocturnal period 
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(P=0.969). There were also no differences in the time spent in target range or hyperglycaemia 
between the three conditions in the 24h or nocturnal periods (P>0.05). 
The incidence of level 1 hypoglycaemia over the 24h period (P=0.266) and nocturnal 
period (P=0.522) was no different between CON, HIT and MICT. There were no differences 
in the incidence of level 2 hypoglycaemia over the 24h (P=0.837) or nocturnal (P=0.703) 
period between conditions.  
There was no report of different levels of snacking between the conditions during the 
CGMS period. Three participants arrived to the laboratory with a blood glucose of  <7 
mmol/L on one trial so consumed ~200ml of Lucozade Sport Orange (20g CHO) and no 
participants arrived with a blood glucose >14 mmol/L.  
Acute change in blood glucose concentration 
Blood glucose concentrations did not drop during HIT (+0.39 ± 0.42 mmol/L) or MICT (-
0.39 ± 0.66 mmol/L) undertaken in the fasted state (P=0.493), with no difference between 
groups (P=1.00; Fig. 3).  
DISCUSSION 
This study examined the effects of a fasted bout of HIT and MICT on acute and 24h glucose 
levels in people with type 1 diabetes. The most important novel findings are that 1) there was 
no difference in the effect of HIT on 24h glucose profiles compared to 30 minutes of MICT, 
2) both HIT and MICT performed following an overnight fast do not increase the incidence
or time spent in hypoglycaemia over the 24h or nocturnal period in comparison to a day of no
exercise, and 3) blood glucose concentration remained stable during a bout of fasted HIT and
during 30 minutes of MICT. This suggests that, a single bout of HIT or 30 minutes of MICT
can be carried out after an overnight fast in people with type 1 diabetes with no increased risk
of hypo- or hyperglycaemia. In addition, provided the starting glucose is between 7-14
mmol/L, our data suggest that there is no need to ingest carbohydrate during and following
HIT and following 30 min MICT in the fasted state.
The current exercise guidelines for people with type 1 diabetes report that aerobic 
exercise decreases blood glucose levels if performed during the postprandial period with 
insulin administration 1. This is supported by a systematic review and meta-analysis 3 that 
aggregated the results from 10 studies to estimate rate of change in glucose concentration in 
response to different types of exercise in people with type 1 diabetes. Garcia-Garcia, 
Kumareswaran, Hovorka, Hernando 3 reported that individuals typically experience a rapid 
decline in glycaemia during continuous exercise (-4.43 mmol/L h-1 on average), whereas the 
response to intermittent high intensity exercise is more varied and dependent on the protocol. 
In contrast, our results showed that blood glucose concentration remained stable during both 
HIT and MICT, and the CGMS data showed no increased risk of hypoglycaemia over the 24h 
period. It is likely that our results do not agree with the findings of Garcia-Garcia, 
Kumareswaran, Hovorka, Hernando 3 because our study was performed in the morning 
following an overnight fast whereas their analysis did not control for time of day or 
nutritional status. Indeed, the most marked drop in blood glucose among the publications 
included in their meta-analysis was by Yamanouchi, Abe, Takeda, Atsumi, Shichiri, Sato 13 
who reported a mean drop of 4.3 mmol/L following a 30 minute walk at <50% V& O2max after 
breakfast.  
The exercise guidelines published by Colberg et al. 1 recommend that exercising while 
fasted may produce a lesser decrease or even a small increase in blood glucose concentration. 
The evidence to support this recommendation, however, is based on only one study that 
investigated the effects of fasted resistance training on glycaemia with no control day as a 
comparison 14. We now provide the first evidence that blood glucose concentrations are stable 
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following both HIT and MICT when undertaken after an overnight fast and with the duration 
of MICT limited to 30 min. The findings of the current investigation should therefore be used 
to inform future exercise guidelines. It is noted though that our observations are in line with 
the international consensus guidelines that no extra CHO should be taken during 30 min of 
MICT under low insulin conditions [12]. 
The use of CGMS allowed us to compare the complete 24h glucose profiles under dietary 
standardisation but otherwise free-living conditions to assess whether there is a delayed 
response in the risk of hypoglycaemia following HIT. Fear of hypoglycaemia during and after 
exercise, as well as during the nocturnal period, is a major barrier to exercise for people with 
type 1 diabetes, so it is essential to objectively establish whether exercise increases the 
hypoglycaemia risk. Here we found no differences in the time spent in level 1 (≤3.9 mmol/L) 
or 2 (≤2.9 mmol/L) hypoglycaemia in both the nocturnal and 24h period following either HIT 
or MICT compared to a day of no exercise. The food diaries that participants completed 
indicated that they consumed the correct food and there was no difference in the amount of 
additional carbohydrate consumed to prevent hypoglycaemia between the conditions. 
Based on our findings it appears that exercising following an overnight fast before using 
short-acting insulin helps to maintain blood glucose stability, irrespective of the mode or 
intensity of the exercise, which means that patients do not need to consume carbohydrate to 
avoid hypoglycaemia during exercise. However, the effects of longer duration MICT sessions 
will have to be tested. Future research should also investigate whether exercising regularly in 
the fasted state improves long-term glycaemic control. Indeed, Kennedy, Nirantharakumar, 
Chimen, Pang, Hemming, Andrews, Narendran 15 suggested that previous research may have 
failed to show glycaemic benefits of exercise because calorie intake and insulin dose around 
the time of exercise has not been controlled. Future research which examines how exercise of 
different type, intensity and duration carried out in the fasted state effects 24h glucose control 
are needed to help to produce more flexible exercise guidelines for people with type 1 
diabetes.  
The authors acknowledge that previous research has investigated the effects of 
intermittent interval exercise in people with type 1 diabetes 7,16. However, this is the first 
study to investigate the effects of a time efficient form of HIT in the fasted state on 24-hour 
glucose profile in people with type 1 diabetes. The results suggest that HIT in the fasted state 
offers a time-efficient exercise mode that does not increase the risk of hypoglycaemia, thus, 
potentially overcoming two major barriers to exercise. As typical low-volume HIT protocols 
require 47-60% lower time commitment to MICT sessions, this may make HIT a more 
attractive training strategy to potentially increase exercise uptake and adherence in people 
with type 1 diabetes. The efficacy of long-term HIT programmes will have to be explored in 
people with type 1 diabetes to determine whether this is an effective and time-efficient 
strategy to improve health. Furthermore, the effects of HIT in the non-fasted state have not 
been investigated. 
The major strength of this investigation lies in the strict dietary standardisation during the 
CGMS period and the fact that the exercise sessions were performed at the same time of day, 
in the same nutritional state. Another strength is that by using CGMS we were able to study 
the individuals under free-living conditions, and thereby take an ecologically valid approach 
to investigate glucose levels following exercise. We also acknowledge that there are some 
limitations that will need to be addressed with further research. Firstly, we did not record 
insulin dose during the CGMS period and participants were not blinded to the CGMS so they 
may have corrected their insulin dosage or taken carbohydrate to prevent lows if they felt it 
was necessary. The fact that there were no differences in food intake between the days 
lessens the chances that change in intake could be the cause. Secondly, the small sample size 
makes it difficult to draw conclusions that can be applied to the wider type 1 diabetes 
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community. However, the sample size is in line with previous investigations that have 
compared the glycaemic effects of different exercise intensities in people with type 1 diabetes 
17-19
. Because many people with type 1 diabetes lead a sedentary lifestyle 20-22, the
development of exercise programmes that increase physical activity levels in these
individuals is warranted. The intention of this investigation was to target a sedentary
population in order to first demonstrate the safety of HIT. This would then provide evidence
to support the development of a time-efficient HIT programme, of which the efficacy could
be tested in a future study. Findings from this study may not be generalisable to endurance
trained individuals with type 1 diabetes, and this should therefore be explored in future
research.” There were three occasions where participants arrived at the laboratory with a
blood glucose of <7 mmol/L on one trial so for safety reasons they ingested ~20g CHO
before the start of exercise. This highlights the difficulty of testing people with type 1
diabetes. However, excluding these participants from the statistical analyses made no
difference to the results so their data were kept in the final analysis. Finally, the MICT was
only 30 minutes in duration so we cannot exclude that prolonged (>30 minutes) MICT
sessions may lead to falls in glycaemia and increase the risk of hypoglycaemia. 30 Minute
MICT sessions are in line with the current exercise recommendations of 30 minutes on 5 days
of the week 1.
In conclusion, this is the first study to demonstrate that there is no increased risk of 
hypoglycaemia over the 24h period or nocturnal period following a single bout of HIT or 30 
minutes of MICT in the fasted state, compared to a day of no exercise in individuals with 
type 1 diabetes. Secondly, blood glucose concentration is unchanged across HIT and MICT 
when undertaken following an overnight fast and having omitted short-acting insulin. 
Therefore, we recommend that in the fasted state, provided blood glucose starts between 7-14 
mmol/L, carbohydrate ingestion is not needed during HIT or 30-minute MICT sessions. As 
HIT may offer a time-efficient and safe alternative for people with type 1 diabetes, future 
research should explore the efficacy of longer-term training programmes. 
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Figure 1 - Study protocol. 24h after the CGMS was inserted participants completed the 
control day. Participants did not attend the laboratory on the control day, but were provided 
with a standardised diet to consume while going about their normal daily activities. 
Following the control day, participants completed the two exercise intervention periods in a 
randomised order separated by at least 48h. The exercise intervention periods were identical 
to the control intervention except participants attended the laboratory following an overnight 
fast and having omitted their short-acting insulin to perform a bout of either high intensity 
interval training (HIT) or moderate intensity continuous training (MICT).  
Figure 2 – Continuous glucose monitor traces. Mean ± SEM continuous glucose monitor 
traces over the 24h period (08:00-08:00h) on the day of no exercise (Control), HIT and 
MICT. The thick lines represent the mean of all the participants’ glucose traces. Exercise was 
performed at approximately 8:30am. The shaded grey area represents the nocturnal period 
(24:00-06:00h).  
Figure 3 - Blood glucose concentrations during HIT and MICT. Mean (±SEM) blood glucose 
concentrations pre and post exercise (A) and individual responses (B) to HIT and MICT 
sessions where the participants were overnight fasted and had omitted their fast-acting 
insulin. 
Table 1 - Summary of continuous glucose monitor data 
CON   HIT   MICT 
24-hr period 
Mean glucose (mmol/L) 9.2 ± 0.6 9.0 ± 0.4 9.5 ± 0.5 
CV (%) 39 ± 2 39 ± 3 38 ± 3 
Time in level 1 hypoglycaemia (%) 5.7 ± 1.4 7.5 ± 3.2 4.9 ± 2.0 
Time in level 2 hypoglycaemia (%) 1.1 ± 0.5 3.1 ± 1.9 1.4 ± 0.7 
Time in range (%) 60.5 ± 5.0 58.1 ± 3.6 59.3 ± 4.8 
Time in hyperglycaemia  (%) 33.7 ± 5.4 34.2 ± 3.6 35.8 ± 5.4 
Incidence of level 1 hypoglycaemia 1.8 ± 0.4 2.2 ± 0.6 1.6 ± 0.5 
Incidence of level 2 hypoglycaemia 0.6 ± 0.3 0.8 ± 0.4 0.6 ± 0.2 
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Incidence of hyperglycaemia 2.7 ± 0.3 3.1 ± 0.3 2.9 ± 0.3 
Nocturnal period 
Mean glucose (mmol/L) 9.0 ± 1.0 9.0 ± 0.7 9.3 ± 0.9 
CV (%) 25 ± 4 28 ± 5 19 ± 4 
Time in level 1 hypoglycaemia (%) 8.9 ± 4.8 8.0 ± 3.6 7.9 ± 4.7 
Time in level 2 hypoglycaemia (%) 1.5 ± 1.0 3.8 ± 2.4 4.0 ± 2.7 
Time in range (%) 59.5 ± 9.7 56.8 ± 8.2 58.5 ± 8.8 
Time in hyperglycaemia (%) 31.3 ± 10.2 35.1 ± 8.7 33.3 ± 9.8 
Incidence of level 1 hypoglycaemia 0.4 ± 0.2 0.5 ± 0.3 0.4 ± 0.2 
Incidence of level 2 hypoglycaemia 0.1 ± 0.1 0.3 ± 0.2 0.2 ± 0.2 
Incidence of hyperglycaemia 0.6 ± 0.1 0.5 ± 0.1 0.6 ± 0.1 
Summary of continuous glucose monitor data for the 24h period (08:00-08:00h) and nocturnal period (24:00-
06:00h) for the control day with no exercise (CON) and the days on which HIT and MICT were performed. 
Level 1 hypoglycaemia (≤3.9 mmol/L), level 2 (severe) hypoglycaemia (≤2.9 mmol/L), target range (4-10 
mmol/L) and hyperglycaemia (≥10 mmol/L). Data are presented as mean ± SEM. There were no differences in 
any of the factors between the conditions (P<0.05). 
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